Guideline Matrix  >
Clinical Specialty: Oncology
Methods Used to Analyze the Evidence: Meta-Analysis
1-20 of 40   Next >
 
1.  
Care of dying adults in the last days of life. 2015 Dec 16. NGC:010873
National Clinical Guideline Centre - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
2.  
Management of early-stage Hodgkin lymphoma. 2015 Dec 8. NGC:010884
Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
3.  
Pembrolizumab for advanced melanoma not previously treated with ipilimumab. 2015 Nov 25. NGC:010860
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
4.  
Melanoma: assessment and management. 2015 Jul 29. NGC:010783
National Collaborating Centre for Cancer - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
5.  
Suspected cancer: recognition and referral. 2005 Jun (revised 2015 Jun 23). NGC:010742
National Collaborating Centre for Cancer - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
6.  
Venous thromboembolism in adults admitted to hospital: reducing the risk. 2007 Apr (revised 2015 Jun). NGC:010743
National Clinical Guideline Centre for Acute and Chronic Conditions - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
7.  
Rituximab in lymphoma and chronic lymphocytic leukemia: a clinical practice guideline, version 3. 2005 Feb 17 (revised 2015 Mar 31). NGC:010715
Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
8.  
Fluorouracil chemotherapy: the My5-FU assay for guiding dose adjustment. 2014 Dec 10. NGC:010621
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
9.  
Colorectal cancer. The diagnosis and management of colorectal cancer. 2005 Aug (revised 2014 Dec). NGC:010624
National Collaborating Centre for Cancer - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
10.  
Erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating anaemia in people with cancer having chemotherapy (including review of TA 142). 2008 May (revised 2014 Nov). NGC:010617
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
11.  
Systemic therapy in men with metastatic castration-resistant prostate cancer: American Society of Clinical Oncology and Cancer Care Ontario clinical practice guideline. 2014 Oct 20. NGC:010623
American Society of Clinical Oncology - Medical Specialty Society; Cancer Care Ontario - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
12.  
Locoregional therapy of locally advanced breast cancer (LABC). 2014 Sep 29. NGC:010699
Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
13.  
14.  
16.  
Prostate cancer: diagnosis and treatment. 2008 Feb (revised 2014 Jan). NGC:010205
National Collaborating Centre for Cancer - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
17.  
The prognostic value of the DNMT3A biomarker in cytogenetically normal patients with acute myeloid leukemia. 2013 Nov 27. NGC:010225
Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
18.  
Neuropathic pain - pharmacological management. The pharmacological management of neuropathic pain in adults in non-specialist settings. 2010 Mar (revised 2013 Nov). NGC:010186
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
19.  
Optimal use of taxanes in metastatic breast cancer (MBC). 2013 Sep. NGC:010373
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
1-20 of 40   Next >